Mediwound Ltd

MediWound Ltd. is a biopharmaceutical company that develops, manufactures, and commercializes bio-therapeutic, non-surgical solutions for tissue repair and regeneration. It operates in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product used to remove eschar in patients with deep partial- and full-thickness thermal burns, supplied to burn centers and hospital burn units. Its development pipeline includes EscharEx, a bromelain-based bioactive enzymatic therapy for chronic and other hard-to-heal wounds, and MW005, a topically applied biological product candidate for non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.